Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.



See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Fabry Disease

Fabry Disease

Explore the pathophysiology and treatment options for Fabry disease, a deficiency of the lysosomal enzyme alpha-galactosidase A

Load more


Anaemia management in people with chronic kidney disease

This guideline covers the management of anaemia in adults, children and young people with a clinical diagnosis of anaemia associated...

Added 2 years ago

Chronic kidney disease in adults: assessment and management

This guideline updates and replaces NICE guideline CG73 (published September 2008). It offers evidence-based advice on the care and treatment...

Added 3 years ago

KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease

This guideline contains chapters on the assessment of lipid status and treatment for dyslipidemia in adults and children. Development of...

Added 4 years ago

Search all guidelines for Chronic kidney disease

Journal articles

Expert Panel Recommendations for the Identification and Management of Hyperkalemia and Role of Patiromer in Patients with Chronic Kidney Disease and Heart Failure.

Virtual panel meetings were conducted among 7 physicians, all of whom are independent experts, including 3 nephrologists, 2 cardiologists, and 2 emergency medicine physicians (the panel).

Added 7 months ago

Risk of corneal ulcer in patients with end-stage renal disease: a retrospective large-scale cohort study.

This retrospective, nationwide, matched cohort study included 92 967 patients with ESRD recruited between 2000 and 2009 from the Taiwan National Health Insurance Research Database.

Added 7 months ago

Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics.

Objective: Recurrent hyperkalemia frequently limits use of renin–angiotensin–aldosterone system inhibitors (RAASi) in chronic kidney disease (CKD) patients with hypertension, diabetes, and/or heart failure.

Added 8 months ago

Search all journal articles for Chronic kidney disease


Test your knowledge of recent NICE guidance

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
Registration required
Subscription fee
Search all CME for Chronic kidney disease